224 related articles for article (PubMed ID: 32523628)
21. Endoscopic Treatment of Early Barrett's Adenocarcinoma and Dysplasia: Focus on Submucosal Cancer.
Frei N; Frei R; Semadeni GM; Jochum W; Brand S; Borovicka J
Digestion; 2019; 99(4):293-300. PubMed ID: 30176662
[TBL] [Abstract][Full Text] [Related]
22. Today's Mistakes and Tomorrow's Wisdom in Endoscopic Treatment and Follow-Up of Barrett's Esophagus.
Barret M
Visc Med; 2022 Jun; 38(3):189-195. PubMed ID: 35814978
[TBL] [Abstract][Full Text] [Related]
23. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
24. The evolution of endoscopic therapy for Barrett's esophagus.
Condon A; Muthusamy VR
Ther Adv Gastrointest Endosc; 2021; 14():26317745211051834. PubMed ID: 34708204
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Barrett's esophagus with high-grade dysplasia.
McAllaster JD; Buckles D; Al-Kasspooles M
Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma.
Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I
Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854
[TBL] [Abstract][Full Text] [Related]
27. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
28. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system.
Gondrie JJ; Pouw RE; Sondermeijer CM; Peters FP; Curvers WL; Rosmolen WD; Ten Kate F; Fockens P; Bergman JJ
Endoscopy; 2008 May; 40(5):370-9. PubMed ID: 18494132
[TBL] [Abstract][Full Text] [Related]
29. Resection of early esophageal neoplasms: The pendulum swings from surgical to endoscopic management.
Sanghi V; Amin H; Sanaka MR; Thota PN
World J Gastrointest Endosc; 2019 Oct; 11(10):491-503. PubMed ID: 31798770
[TBL] [Abstract][Full Text] [Related]
30. Outcomes in patients who have failed endoscopic therapy for dysplastic Barrett's metaplasia or early esophageal cancer.
Hunt BM; Louie BE; Schembre DB; Bohorfoush AG; Farivar AS; Aye RW
Ann Thorac Surg; 2013 May; 95(5):1734-40. PubMed ID: 23561804
[TBL] [Abstract][Full Text] [Related]
31. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of liquid nitrogen cryotherapy for Barrett's esophagus after endoscopic resection of intramucosal cancer: A multicenter study.
Trindade AJ; Pleskow DK; Sengupta N; Kothari S; Inamdar S; Berkowitz J; Kaul V
J Gastroenterol Hepatol; 2018 Feb; 33(2):461-465. PubMed ID: 28770555
[TBL] [Abstract][Full Text] [Related]
33. Management of Nodular Neoplasia in Barrett's Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection.
Belghazi K; Bergman JJGHM; Pouw RE
Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):461-470. PubMed ID: 28577767
[TBL] [Abstract][Full Text] [Related]
34. Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility.
Beaumont H; Gondrie JJ; McMahon BP; Pouw RE; Gregersen H; Bergman JJ; Boeckxstaens GE
Endoscopy; 2009 Jan; 41(1):2-8. PubMed ID: 19160152
[TBL] [Abstract][Full Text] [Related]
35. Endoscopic Treatment of High-Grade Dysplasia and Intramucosal Esophageal Adenocarcinoma.
Reed CC; Shaheen NJ
J Laparoendosc Adv Surg Tech A; 2016 Oct; 26(10):768-772. PubMed ID: 27541732
[TBL] [Abstract][Full Text] [Related]
36. Long-term results of the mucosal ablation of Barrett's esophagus: efficacy and recurrence.
Saligram S; Tofteland N; Wani S; Gupta N; Mathur S; Vennalaganti P; Kanakadandi V; Giacchino M; Higbee A; Lim D; Rastogi A; Bansal A; Sharma P
Endosc Int Open; 2015 Jun; 3(3):E189-94. PubMed ID: 26171429
[TBL] [Abstract][Full Text] [Related]
37. Sixteen-year follow-up of Barrett's esophagus, endoscopically treated with argon plasma coagulation.
Milashka M; Calomme A; Van Laethem JL; Blero D; Eisendrath P; Le Moine O; Devière J
United European Gastroenterol J; 2014 Oct; 2(5):367-73. PubMed ID: 25360314
[TBL] [Abstract][Full Text] [Related]
38. Subsquamous intestinal metaplasia after ablation of Barrett's esophagus: frequency and importance.
Mashimo H
Curr Opin Gastroenterol; 2013 Jul; 29(4):454-9. PubMed ID: 23674187
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic Eradication Therapy in Barrett's Esophagus.
Eluri S; Shaheen NJ
Tech Gastrointest Endosc; 2017 Jul; 19(3):137-142. PubMed ID: 29269998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
